Once-daily budesonide inhalation suspension for the treatment of persistent asthma in infants and young children
Authors:
- David P. SkonerDSDavid P. Skoner
- Stanley J. SzeflerSSStanley J. Szefler
- Karen Walton-BowenKWKaren Walton-Bowen
- Mario Cruz-RiveraMCMario Cruz-Rivera
- Joseph A. SmithJSJoseph A. Smith
- 1 September 1999
- journal article
- clinical trial
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 83 (3) , 231-239
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Rapid induction of clinical response with a short-term high-dose starting schedule of budesonide nebulizing suspension in young children with recurrent wheezing episodesJournal of Allergy and Clinical Immunology, 1998
- Budesonide delivered by Turbuhaler is effective in a dose-dependent fashion when used in the treatment of adult patients with chronic asthmaJournal of Allergy and Clinical Immunology, 1998
- A comparison of the efficacy and safety of inhaled corticosteroids in asthmaAllergy, 1997
- Aggressive treatment of childhood asthma with local steroids. Good or bad?Allergy, 1996
- Budesonide treatment of moderate and severe asthma in children: A dose-response studyJournal of Allergy and Clinical Immunology, 1995
- Efficacy of cromoglycate in persistently wheezing infants.Archives of Disease in Childhood, 1994
- Changes in asthma prevalence: two surveys 15 years apart.Archives of Disease in Childhood, 1989
- Controlled trial of budesonide given by the nebuhaler in preschool children with asthma.BMJ, 1988
- Nebulisead Sodium Cromoglycate in the Treatment of Wheezy Bronchitis A Multicentre Double‐Blind Placebo Controlled StudyAllergy, 1986
- Nebulised sodium cromoglycate in recurrently wheezy preschool children.Archives of Disease in Childhood, 1985